Trial NCT04135352

View at ClinicalTrials.gov 
Org. Study IDs: V938-001
Secondary IDs: 2020-003431-25 V938-001

Last trial update was posted on 2022-11-04

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasm Metastasis

Other Conditions


Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID